<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource><Section SecID="390" OrdBy="100" Name="General"><Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Routine preventive services for children and adolescents (ages 2-21).&lt;/div&gt;" /></Field><Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Michigan Quality Improvement Consortium. Routine preventive services for children and adolescents (ages 2-21). Southfield (MI): Michigan Quality Improvement Consortium; 2013 May. 1 p. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Michigan Quality Improvement Consortium. Routine preventive services for children and adolescents (ages 2-21). Southfield (MI): Michigan Quality Improvement Consortium; 2011 May. 1 p.&lt;/p&gt;&lt;/div&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="ICD9CM: Accident caused by unspecified firearm missile  (E922.9); Acute poliomyelitis, unspecified, poliovirus, unspecified type  (045.90); Administration of measles-mumps-rubella vaccine  (99.48); Anxiety state, unspecified  (300.00); Burn of unspecified site, unspecified degree  (949.0); Child abuse, unspecified  (995.50); Counseling on injury prevention  (V65.43); Counseling on other sexually transmitted diseases  (V65.45); Counseling on substance use and abuse  (V65.42); Diphtheria, unspecified  (032.9); Fall from skateboard  (E885.2); Human immunodeficiency virus [HIV] disease  (042); Human papillomavirus in conditions classified elsewhere and of unspecified site  (079.4); Influenza with other respiratory manifestations  (487.1); Injury by burns or fire, undetermined whether accidentally or purposely inflicted  (E988.1); Major depressive affective disorder, recurrent episode, unspecified  (296.30); Major depressive affective disorder, single episode, unspecified  (296.20); Malignant neoplasm of cervix uteri, unspecified site  (180.9); Measles without mention of complication  (055.9); Meningitis, unspecified  (322.9); Mumps without mention of complication  (072.9); Other and unspecified alcohol dependence, unspecified  (303.90); Other and unspecified diseases of the oral soft tissues  (528.9); Other venereal diseases due to chlamydia trachomatis, unspecified site  (099.50); Overweight  (278.02); Rubella without mention of complication  (056.9); Screening for depression  (V79.0); Tetanus  (037); Tobacco use disorder  (305.1); Unspecified accident  (E928.9); Unspecified delay in development  (315.9); Unspecified disorder of lipoid metabolism  (272.9); Unspecified disorder of the teeth and supporting structures  (525.9); Unspecified drug dependence, unspecified  (304.90); Unspecified malignant neoplasm of skin, site unspecified  (173.90); Unspecified visual disturbance  (368.9); Varicella without mention of complication  (052.9); Venereal disease, unspecified  (099.9); Whooping cough due to bordetella pertussis [B. pertussis]  (033.0)"/><FieldValue Value="MSH: Accident Prevention ; Accidents ; Accidents, Traffic ; Adaptation, Psychological ; Adolescent Health Services ; Adolescent Nutritional Physiological Phenomena ; AIDS Serodiagnosis ; Alcohol-Related Disorders ; Alcoholism ; Anxiety ; Body Mass Index ; Body Weight ; Bullying ; Burns ; Chickenpox ; Chickenpox Vaccine ; Child Abuse ; Child Health Services ; Child Nutritional Physiological Phenomena ; Chlamydia ; Dental Care ; Dental Health Services ; Depression ; Developmental Disabilities ; Diphtheria ; Diphtheria-Tetanus-acellular Pertussis Vaccines ; Exercise ; HIV Infections ; Hypercholesterolemia ; Immunization ; Immunization Programs ; Immunization Schedule ; Influenza Vaccines ; Influenza, Human ; Lipid Metabolism Disorders ; Mass Screening ; Measles ; Measles Vaccine ; Measles-Mumps-Rubella Vaccine ; Meningitis ; Meningococcal Vaccines ; Motor Activity ; Mumps ; Mumps Vaccine ; Overweight ; Papillomavirus Infections ; Papillomavirus Vaccines ; Patient Education as Topic ; Poisoning ; Poliomyelitis ; Poliovirus Vaccines ; Pregnancy, Unplanned ; Preventive Health Services ; Risk Assessment ; Rubella ; Rubella Vaccine ; Safety ; Sexually Transmitted Diseases ; Skin Neoplasms ; Stomatognathic Diseases ; Stress, Psychological ; Substance-Related Disorders ; Suicide ; Tetanus ; Tobacco Smoke Pollution ; Tobacco Use Disorder ; Tooth Diseases ; Vaccines, Combined ; Violence ; Vision Disorders ; Vision Tests ; Whooping Cough ; Wounds and Injuries ; Wounds, Gunshot "/><FieldValue Value="MTH: Accidents ; Accidents, Traffic ; AIDS Serodiagnosis measurement ; Alcoholic Intoxication, Chronic ; Anxiety ; Anxiety state ; Body mass index procedure ; Body Weight ; Bullying ; Burn injury ; Chickenpox ; Chickenpox Vaccine ; child abuse behavior ; Child Health Services ; Chlamydia ; Cholesterol measurement test ; Contraception care education ; Dental Diseases ; Dental Health Services ; Dental Procedures ; Depression screen ; Developmental delay (disorder) ; Developmental Disabilities ; Diphtheria ; Drug abuse ; DRUG DEPENDENCE ; Encounter due to screening for depression ; Exercise ; Gunshot wound ; HIV Infections ; HIV screen ; Human papillomavirus infection in conditions classified elsewhere and of unspecified site ; Hypercholesterolemia ; Immunization ; Influenza ; Influenza virus vaccine ; Lipid Metabolism Disorders ; Malignant tumor of cervix ; Measles ; Measles Vaccine ; Measles-mumps-rubella vaccination ; Measles-Mumps-Rubella Vaccine ; Meningococcal vaccine ; Mental Depression ; Mumps ; Mumps Vaccine ; OVERWEIGHT ; Patient education (procedure) ; Pertussis ; Physical activity ; Poisoning ; Poliomyelitis ; Poliovirus Vaccines ; Psychological adjustment ; Risk Assessment ; Rubella ; Rubella virus vaccine ; Rubella without complication ; Safety ; Screening for venereal disease ; Sexually Transmitted Diseases ; Skin Neoplasms ; Stress, Psychological ; Substance abuse problem ; Suicide ; Tetanus ; Tobacco Use Disorder ; Tooth Diseases ; Traumatic injury ; Unplanned pregnancy ; Vision Disorders ; Vision Tests ; Visual disturbance ; Wounds and Injuries "/><FieldValue Value="PDQ: skin tumor ; substance abuse disorder ; tobacco use disorder "/><FieldValue Value="SNOMEDCT_US: Accident caused by firearm missile  (218081007); Accident prevention  (134185000); Alcohol-induced organic mental disorder  (29212009); Alcoholism  (284591009); Alcoholism  (66590003); Alcoholism  (7200002); Anxiety  (48694002); Anxiety state  (198288003); At risk for suicide  (225444004); At risk for suicide  (41501003); Bicycle accident  (386663009); Body weight  (27113001); Bullying  (247997008); Burn injury  (125666000); Burn injury  (48333001); Child abuse  (418189009); Child nutrition  (87346005); Chlamydia  (16241000); Contraception care education  (408968008); Dental-oral procedure AND/OR service  (108306002); Dental-oral procedure AND/OR service  (225362009); Depression screening  (171207006); Developmental delay  (248290002); Developmental disorder  (5294002); Diphtheria  (276197005); Diphtheria  (397428000); Diphtheria + tetanus + acellular pertussis vaccine  (429321000124106); Disease due to Papilloma virus  (30415006); Disorder of lipid metabolism  (267431006); Disorder of teeth AND/OR supporting structures  (105995000); Disorder of vision  (128127008); Disorder of vision  (95677002); Drug abuse  (26416006); Drug dependence  (191816009); Drug dependence  (2403008); Drug dependence  (6525002); Epidemic acute poliomyelitis  (398102009); Epidemic acute poliomyelitis  (398256009); Exercise  (183301007); Exercise  (256235009); Exercise  (61686008); Gunshot wound  (283545005); Gunshot wound  (56768003); HIV screening  (171121004); Human immunodeficiency virus infection  (86406008); Hypercholesterolemia  (13644009); Immunization  (127785005); Influenza  (6142004); Influenza virus vaccine  (396425006); Influenza virus vaccine  (46233009); Influenza with respiratory manifestation other than pneumonia  (63039003); Malignant tumor of cervix  (363354003); Measles  (14189004); Measles + mumps + rubella + varicella vaccine  (419550004); Measles vaccine  (386012008); Measles vaccine  (396427003); Measles, mumps and rubella vaccine  (396429000); Measles, mumps and rubella vaccine  (61153008); Measles-mumps-rubella vaccination  (38598009); Meningitis  (7180009); Meningococcus vaccine  (423531006); Meningococcus vaccine  (424891007); Mumps  (240526004); Mumps  (36989005); Mumps vaccine  (396431009); Mumps vaccine  (90043005); Mumps without complication  (111870000); Neoplasm of skin  (126488004); Overweight  (238131007); Parent education: adolescent  (386380002); Parent education: childrearing family  (386381003); Patient education  (311401005); Pertussis  (27836007); Physical activity  (48761009); Physical activity  (68130003); Poisoning  (75478009); Poisoning / injury  (370122001); Poliovirus vaccine  (111164008); Poliovirus vaccine  (415129008); Preventing injury  (275826003); Recurrent major depressive episodes  (268621008); Recurrent major depressive episodes  (66344007); Risk assessment  (225338004); Rubella  (36653000); Rubella vaccine  (386013003); Rubella vaccine  (396438003); Rubella without complication  (111867004); Sexually transmitted infectious disease  (8098009); Single major depressive episode  (268620009); Single major depressive episode  (36923009); Substance abuse  (66214007); Substance abuse counseling  (313071005); Suicide  (44301001); Tetanus  (276202003); Tetanus  (76902006); Tobacco dependence, continuous  (191887008); Tooth disorder  (234947003); Traumatic injury  (417746004); Unplanned pregnancy  (83074005); Varicella  (38907003); Varicella virus vaccine  (108729007); Varicella virus vaccine  (396442000); Venereal disease screening  (171128005); Victim of bullying  (225820007); Visual disturbance  (131182003); Visual disturbance  (63102001); Visual testing  (268360001)"/></Field></Section><Section SecID="396" OrdBy="300" Name="Scope"><Field FieldID="140" OrdBy="305" ID="397" Name="Disease/Condition(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Preventable diseases or conditions such as:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Infectious diseases including diphtheria, tetanus, pertussis, poliomyelitis, measles, mumps, rubella, varicella, influenza, meningitis, sexually transmitted infections including chlamydia, human papillomavirus (HPV), and human immunodeficiency virus (HIV) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Overweight &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Oral and dental diseases &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Skin cancer &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Depression, suicide ideation, anxiety, stress &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Harm from violence or abuse/bullying &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Alcohol and drug abuse &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Injuries due to motor vehicles, bicycle riding, skateboarding, skating, etc. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Injuries from burns, poisoning, firearms, water &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Tobacco use/exposure to second-hand smoke &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Hypercholesterolemia &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Unintended pregnancy &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Vision disorders &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Developmental delays &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" /></Field><Field FieldID="103" OrdBy="310" ID="398" Name="Guideline Category" Type="picklist-many"><FieldValue Value="Counseling" /><FieldValue Value="Prevention" /><FieldValue Value="Risk Assessment" /><FieldValue Value="Screening" /></Field><Field FieldID="113" OrdBy="315" ID="399" Name="Clinical Specialty" Type="picklist-many"><FieldValue Value="Family Practice" /><FieldValue Value="Obstetrics and Gynecology" /><FieldValue Value="Pediatrics" /><FieldValue Value="Preventive Medicine" /></Field><Field FieldID="114" OrdBy="320" ID="400" Name="Intended Users" Type="picklist-many"><FieldValue Value="Advanced Practice Nurses" /><FieldValue Value="Health Plans" /><FieldValue Value="Physician Assistants" /><FieldValue Value="Physicians" /></Field><Field FieldID="129" OrdBy="325" ID="401" Name="Guideline Objective(s)" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;To achieve significant, measurable improvements in the management of routine preventive services for children and adolescents (ages 2 to 21) through the development and implementation of common evidence-based clinical practice guidelines &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To design concise guidelines that are focused on key management components of routine preventive services for children and adolescents (ages 2 to 21) to improve outcomes &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="132" OrdBy="330" ID="402" Name="Target Population" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Children and adolescents ages 2 to 21 years&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="133" OrdBy="335" ID="403" Name="Interventions and Practices Considered" Type="text"><FieldValue Value="&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Assessment of risk factors &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Parent and child age-appropriate education and counseling regarding:&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Nutrition, physical activity, dental health, violence and abuse/bullying, sexually transmitted infection prevention, depression, suicide threats, alcohol and drug abuse, anxiety, stress reduction, coping skills, immunizations, skin cancer &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Motor-vehicle and bicycle safety, poison prevention, burn and injury prevention &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Preconception and pregnancy prevention &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Screening for tobacco use/second-hand exposure, overweight, cholesterol, sexually transmitted infections, human immunodeficiency virus (HIV), depression, vision disorders, developmental delays &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Immunizations:&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Diphtheria, tetanus, and acellular pertussis vaccine (DTaP), tetanus-diphtheria-acellular pertussis vaccine (Tdap) &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Inactivated poliovirus vaccine (IPV) &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Measles, mumps, and rubella (MMR) or measles, mumps, rubella, and varicella vaccine (MMRV) &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Varicella vaccine &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Meningococcal vaccine &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Influenza vaccine &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Human papillomavirus (HPV) vaccine &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;" /></Field><Field FieldID="134" OrdBy="340" ID="404" Name="Major Outcomes Considered" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="405" OrdBy="400" Name="Methodology"><Field FieldID="109" OrdBy="405" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many"><FieldValue Value="Searches of Electronic Databases" /></Field><Field FieldID="135" OrdBy="410" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The Michigan Quality Improvement Consortium (MQIC) health care analyst conducts a search of current literature in support of the guideline topic. Computer database searches are used to identify published studies, existing protocols and/or national guidelines on the selected topic developed by organizations such as the American Diabetes Association, American Heart Association, American Academy of Pediatrics, etc. If available, clinical practice guidelines from participating MQIC health plans and Michigan health systems are also used to develop a framework for the new guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For the current update of the guideline the following databases were searched from 2011 to 2013: American Academy of Pediatrics, United States Preventive Services Task Force (USPSTF), and Advisory Committee on Immunization Practices (ACIP). No search terms were used and no specific inclusion/exclusion criteria were applied.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="136" OrdBy="415" ID="408" Name="Number of Source Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="115" OrdBy="420" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice"><FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" /></Field><Field FieldID="149" OrdBy="425" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Levels of Evidence for the Most Significant Recommendations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;ol style=&quot;list-style-type: upper-alpha;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Randomized controlled trials &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Controlled trials, no randomization &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Observational studies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Opinion of expert panel &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&lt;/div&gt;" /></Field><Field FieldID="116" OrdBy="430" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many"><FieldValue Value="Review" /></Field><Field FieldID="150" OrdBy="435" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="112" OrdBy="440" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice"><FieldValue Value="Expert Consensus" /></Field><Field FieldID="145" OrdBy="445" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Using information obtained from literature searches and available health plan guidelines on the designated topic, the Michigan Quality Improvement Consortium (MQIC) health care analyst prepares a draft guideline to be reviewed by the Medical Directors' committee at one of their scheduled meetings. Priority is given to recommendations with [A] and [B] levels of evidence (see the &quot;Rating Scheme for the Strength of the Evidence&quot; field).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The initial draft guideline is reviewed, evaluated, and revised by the committee, resulting in draft two of the guideline. Additionally, the Michigan Academy of Family Physicians participates in guideline development at the onset of the process and throughout the guideline development procedure. The MQIC guideline feedback form and draft two of the guideline are distributed to the Medical Directors, as well as the MQIC measurement and implementation group members, for review and comments. Feedback from members is collected by the MQIC health care analyst and prepared for review by the Medical Directors' committee at their next scheduled meeting. The review, evaluation, and revision process with several iterations of the guideline may be repeated over several meetings before consensus is reached on a final draft guideline.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="146" OrdBy="450" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="148" OrdBy="460" ID="417" Name="Cost Analysis" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A formal cost analysis was not performed and published cost analyses were not reviewed.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="104" OrdBy="465" ID="418" Name="Method of Guideline Validation" Type="picklist-choice"><FieldValue Value="External Peer Review" /><FieldValue Value="Internal Peer Review" /></Field><Field FieldID="130" OrdBy="470" ID="419" Name="Description of Method of Guideline Validation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;When consensus is reached on the final draft guideline, the Medical Directors approve the guideline for external distribution to practitioners with review and comments requested via the Michigan Quality Improvement Consortium (MQIC) health plans (health care analyst distributes final draft to Medical Directors' committee, measurement and implementation groups to solicit feedback).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The MQIC health care analyst also forwards the approved guideline draft to appropriate state medical specialty societies and physicians with expertise in the related field for their input. After all feedback is received from external reviews, it is presented for discussion at the next scheduled committee meeting. Based on feedback, subsequent guideline review, evaluation, and revision may be required prior to final guideline approval.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The MQIC Medical Directors approved this guideline in May 2013.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="420" OrdBy="500" Name="Recommendations"><Field FieldID="151" OrdBy="505" ID="421" Name="Major Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The level of evidence grades (&lt;strong&gt;A-D&lt;/strong&gt;) are provided for the most significant recommendations and are defined at the end of the &quot;Major Recommendations&quot; field.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The following guideline provides recommendations for routine preventive services for children and adolescents ages 2-21 years. Children at increased risk may warrant additional services, e.g., Early Periodic Screening, Diagnosis, and Treatment (EPSDT) Program&lt;sup&gt;1&lt;/sup&gt;.&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Routine Preventive Services for Children and Adolescents Ages 2-21 Years&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Recommendation&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;2-6 years&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;7-12 years&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;13-21 years&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Annual health, developmental and risk assessments&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Parent and child age-appropriate education and counseling:&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Nutrition, physical activity, dental health&lt;sup&gt;2&lt;/sup&gt;, violence and abuse/bullying (Michigan abuse and neglect hotline 855-444-3911), sexually transmitted infection (STI) prevention, suicide threats, alcohol and drug abuse, anxiety, stress reduction, coping skills, immunizations, skin cancer prevention &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Helmet use and protective gear for bicycle riding, skateboarding, skating, etc. &lt;strong&gt;[B]&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Motor vehicle safety&lt;sup&gt;3&lt;/sup&gt; - Car seat, booster seat, seat belt use &lt;strong&gt;[B]&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Poison prevention - Keep the National Poison Control number (800-222-1222) readily accessible; use child resistant containers; dispose of expired or unused medications &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Burn prevention - Install smoke detectors and test twice a year; carbon monoxide detectors; water heater temperature and fire prevention &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Injury prevention - Firearm safety; water safety; cardiopulmonary resuscitation (CPR) training &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Tobacco use screening: Establish tobacco use and secondhand exposure&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Weight assessment screening&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;3&quot;&gt;Record height, weight and body mass index (BMI) percentile annually&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Chlamydia and STI screening &lt;strong&gt;[A]&lt;/strong&gt; (&lt;em&gt;rescreen if change in risk status&lt;/em&gt;)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;All sexually active adolescents&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Human immunodeficiency virus (HIV) screening &lt;strong&gt;[A]&lt;/strong&gt; (&lt;em&gt;age &amp;ge;15, younger if at increased risk&lt;/em&gt;)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Preconception and pregnancy prevention counseling. Folic acid 400 &amp;micro;g daily&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;2&quot;&gt;Preventive counseling beginning at age 12, or earlier if sexually active&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Depression screening &lt;strong&gt;[B]&lt;/strong&gt; (age &amp;ge;12)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Vision screening &lt;strong&gt;[A]&lt;/strong&gt;&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;br /&gt;&#xD;&#xA;            (prior to school enrollment)&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;br /&gt;&#xD;&#xA;            Every 2 years&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;br /&gt;&#xD;&#xA;            Every 3 years&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Developmental screening&lt;sup&gt;4&lt;/sup&gt; &lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X (30 months)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Cholesterol screening (&lt;em&gt;if at increased risk, screen ages 2-8 and 12-16&lt;/em&gt;) &lt;strong&gt;[B]&lt;/strong&gt; &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;br /&gt;&#xD;&#xA;            (ages 9-11)&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;br /&gt;&#xD;&#xA;            (ages 17-21)&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;EPSDT: age specific exam and anticipatory guidance template (&lt;a href=&quot;http://ihcs.msu.edu/qi/epsdt_clinician_toolkit.html&quot; title=&quot;Institute for Health Policy (MSU) Web site&quot;&gt;http://ihcs.msu.edu/qi/epsdt_clinician_toolkit.html&lt;/a&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Adequate fluoridation, limited sugar intake, home oral care, avoid baby bottle use&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;American Academy of Pediatrics (AAP) Policy Statement-Child Passenger Safety (&lt;a href=&quot;http://pediatrics.aappublications.org/content/127/4/788.full&quot; title=&quot;AAP Policy Web site&quot;&gt;http://pediatrics.aappublications.org/content/127/4/788.full&lt;/a&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;AAP Section on Developmental and Behavioral Pediatrics (&lt;a href=&quot;http://www2.aap.org/sections/dbpeds/screening.asp&quot; title=&quot;AAP Web site&quot;&gt;http://www2.aap.org/sections/dbpeds/screening.asp&lt;/a&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Immunizations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;For updated immunization schedules see &lt;a href=&quot;http://www.cdc.gov/vaccines/acip/index.html&quot; title=&quot;CDC Web site&quot; target=&quot;_blank&quot;&gt;http://www.cdc.gov/vaccines/acip/index.html&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Use combination vaccines to minimize the number of injections. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Update the Michigan Care Improvement Registry (MCIR). &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;br /&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Routine Preventive Services for Children and Adolescents&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Vaccines&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;4-6 years&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;11-12 years&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;15-18 years&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;DTaP &lt;strong&gt;[A]&lt;/strong&gt;&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;Tdap&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;IPV&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;MMR (MMRV) &lt;strong&gt;[A]&lt;/strong&gt;&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Varicella &lt;strong&gt;[A]&lt;/strong&gt;&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Meningococcal (MCV4)&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;Booster at age 16 years&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Influenza &lt;strong&gt;[B]&lt;/strong&gt;&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot; colspan=&quot;3&quot;&gt;Two doses for the first year; one dose annually thereafter.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Human papillomavirus (&lt;em&gt;3-dose series, minimum age 9&lt;/em&gt;)&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;X&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;Abbreviations: DTaP, diphtheria, tetanus, acellular pertussis; IPV, inactivated poliovirus vaccine; MCV4, meningococcal conjugate vaccine; MMR, measles, mumps, rubella; MMRV, measles, mumps, rubella, varicella; Tdap, tetanus-diphtheria-acellular pertussis vaccine&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Definitions&lt;/span&gt;&lt;/strong&gt;:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Levels of Evidence for the Most Significant Recommendations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: upper-alpha;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Randomized controlled trials &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Controlled trials, no randomization &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Observational studies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Opinion of expert panel &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&lt;/div&gt;" /></Field><Field FieldID="138" OrdBy="515" ID="423" Name="Clinical Algorithm(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None provided&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations"><Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The type of evidence is provided for the most significant recommendations (see the &quot;Major Recommendations&quot; field).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline is based on several sources, including:&amp;nbsp;Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents Summary Report, National Heart Lung and Blood Institute, NIH Publication No. 12-7486-A, October 2012; Preventive Services for Children and Adolescents, Institute for Clinical Systems Improvement, 2012 (&lt;a href=&quot;https://www.icsi.org/&quot; title=&quot;ICSI Web site&quot;&gt;www.icsi.org&lt;/a&gt;); and American Academy of Pediatrics (AAP) Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 3rd Edition, 2008.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations"><Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Through a collaborative approach to developing and implementing common clinical practice guidelines and performance measures for routine preventive services for children and adolescents ages 2 to 21, Michigan health plans will achieve consistent delivery of evidence-based services and better health outcomes. This approach also will augment the practice environment for physicians by reducing the administrative burdens imposed by compliance with diverse health plan guidelines and associated requirements.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="432" OrdBy="900" Name="Qualifying Statements"><Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This guideline lists core management steps. Individual patient considerations and advances in medical science may supersede or modify these recommendations.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline"><Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Approved Michigan Quality Improvement Consortium (MQIC) guidelines are disseminated through email, U.S. mail, and websites.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The MQIC health care analyst prepares approved guidelines for distribution. Portable Document Format (PDF) versions of the guidelines are used for distribution.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The MQIC health care analyst distributes approved guidelines to MQIC membership via email.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The MQIC health care analyst submits request to Web site vendor to post approved guidelines to the &lt;a href=&quot;http://www.mqic.org/&quot; title=&quot;MQIC Web site&quot;&gt;MQIC Web site&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The MQIC health care analyst completes an annual statewide postcard mailing to physicians in all areas of medicine including primary care and specialties. The postcard provides the complete list of MQIC guidelines and includes which guidelines have been recently revised, which are coming up for revision, and any new published guidelines.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The statewide mailing list is derived from the Blue Cross Blue Shield of Michigan (BCBSM) provider database. Approximately 95% of the state's M.D.'s and 96% of the state's D.O.'s are included in the database.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The MQIC health care analyst submits request to the National Guideline Clearinghouse (NGC) to post approved guidelines to the &lt;a href=&quot;http://www.guideline.gov&quot; title=&quot;NGC Web site&quot; target=&quot;_blank&quot;&gt;NGC Web site&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="117" OrdBy="1015" ID="437" Name="Implementation Tools" Type="picklist-many"><FieldValue Value="Tool Kits" /></Field></Section><Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories"><Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many"><FieldValue Value="Staying Healthy" /></Field><Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many"><FieldValue Value="Effectiveness" /><FieldValue Value="Patient-centeredness" /></Field></Section><Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability"><Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Michigan Quality Improvement Consortium. Routine preventive services for children and adolescents (ages 2-21). Southfield (MI): Michigan Quality Improvement Consortium; 2013 May. 1 p. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This guideline is based on several sources, including:&amp;nbsp;Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents Summary Report, National Heart Lung and Blood Institute, NIH Publication No. 12-7486-A, October 2012; Preventive Services for Children and Adolescents, Institute for Clinical Systems Improvement, 2012 (&lt;a href=&quot;https://www.icsi.org/&quot; title=&quot;ICSI Web site&quot;&gt;www.icsi.org&lt;/a&gt;); and American Academy of Pediatrics (AAP) Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 3rd Edition, 2008.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text"><FieldValue Value="2007 May (revised 2013 May)" /></Field><Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p"><FieldValue Value="Michigan Quality Improvement Consortium - Professional Association" /></Field><Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Michigan Quality Improvement Consortium&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Michigan Quality Improvement Consortium Medical Directors' Committee&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Physician representatives from the 13 participating Michigan Quality Improvement Consortium health plans, Michigan State Medical Society, Michigan Osteopathic Association, Michigan Association of Health Plans, Michigan Department of Community Health, Michigan Peer Review Organization, and the University of Michigan Health System&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Standard disclosure is requested from all individuals participating in the Michigan Quality Improvement Consortium (MQIC) guideline development process, including those parties who are solicited for guideline feedback (e.g., health plans, medical specialty societies). Additionally, members of the MQIC Medical Directors' Committee are asked to disclose all commercial relationships as well.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Michigan Quality Improvement Consortium. Routine preventive services for children and adolescents (ages 2-21). Southfield (MI): Michigan Quality Improvement Consortium; 2011 May. 1 p.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Electronic copies: Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://www.mqic.org/pdf/mqic_routine_preventive_services_for_children_and_adolescents_ages_2_to_21_cpg.pdf&quot; title=&quot;MQIC Web site&quot;&gt;Michigan Quality Improvement Consortium Web site&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following is available: &lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Early Periodic Screening, Diagnosis and Treatment (EPSDT) physician toolkit including HME forms newborn to 20 years of age (MSUCOM Institute for Health Care Studies). Available from the &lt;a href=&quot;http://www.mqic.org/physician-tools.htm&quot; title=&quot;MQIC Web site&quot;&gt;Michigan Quality Improvement Consortium Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" /></Field><Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None available&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary was completed by ECRI Institute on March 5, 2008. The information was verified by the guideline developer on March 12, 2008. This NGC summary was updated by ECRI Institute on November 6, 2009. The updated information was verified by the guideline developer on December 10, 2009. This summary was updated by ECRI Institute on November 12, 2010 following the U.S. Food and Drug Administration (FDA) advisory on Afluria (influenza virus vaccine). This summary was updated by ECRI Institute on August 25, 2011. The updated information was verified by the guideline developer on September 2, 2011. This summary was updated by ECRI Institute on August 22, 2013. The updated information was verified by the guideline developer on October 2, 2013.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary is based on the original guideline, which may be reproduced with the citation developed by the Michigan Quality Improvement Consortium.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at &lt;a href=&quot;/about/inclusion-criteria.aspx&quot;&gt;http://www.guideline.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" /></Field></Section></Version>
